JPMorgan analyst Ryan Brinkman lowered the firm’s price target on Rivian (RIVN) to $9 from $10 and keeps an Underweight rating on the shares. The firm trimmed estimates to reflect bigger EBITDA losses and free cash flow outflow versus consensus in 2026. Rivian’s outlook indicates the R2 benefits will be a 2027 event, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RIVN: